Milkify is building solutions in the human milk-based nutrition space, aiming to improve how infants and others benefit from breast-milk–derived nourishment. While precise product details were not disclosed, the company positions itself at the intersection of biotechnology and consumer health. Leadership emphasizes a strong vision for expanding human-milk nutrition and views the latest financing as a springboard into its next phase of execution. The team highlights a supportive investor group that understands the regulatory and operational complexities of the category. Financially, Milkify just secured an oversubscribed Series Seed round, bringing new institutional, biotech, and angel investors onto the cap table while existing backers increased their commitments. The fresh capital will fund product development and scale-up efforts in the coming years. No revenue, user, or geographic metrics were provided in the announcement.

Total raised

$0M

Funding rounds

2

Latest round

Convertible Note

Latest activity

Sep 2023